Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Medtronic
US Army
Chinese Patent Office
Cantor Fitzgerald
Accenture
McKesson
QuintilesIMS
Farmers Insurance

Generated: April 21, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 075179

« Back to Dashboard

NDA 075179 describes NABUMETONE, which is a drug marketed by Apotex Inc, Casi Pharms Inc, Chartwell Molecules, Copley Pharm, Impax Labs Inc, Invagen Pharms, Lupin Ltd, Mylan Pharms Inc, Oxford Pharms, Sandoz, Sciegen Pharms Inc, and Watson Labs, and is included in twelve NDAs. It is available from thirty-nine suppliers. Additional details are available on the NABUMETONE profile page.

The generic ingredient in NABUMETONE is nabumetone. There are twenty drug master file entries for this compound. Thirty-nine suppliers are listed for this compound. Additional details are available on the nabumetone profile page.
Summary for 075179
Tradename:NABUMETONE
Applicant:Copley Pharm
Ingredient:nabumetone
Patents:0
Therapeutic Class:Analgesics
Anti-inflammatory Agents
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength750MG
Approval Date:Jun 6, 2000TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Harvard Business School
US Army
Moodys
Cipla
McKesson
US Department of Justice
Queensland Health
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.